| |
| | Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell ... |
 | | Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma -- Moskowitz et al. |
 | | Articles by Moskowitz, C. Articles by Zelenetz, A. Journal of Clinical Oncology, Vol 17, Issue 12 (December), 1999: 3776-3785 |
 | | From the Lymphoma and Hematology Services, Department of Medicine, and Departments of Radiotherapy, Pathology, and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY. |
| www.jco.org /cgi/content/abstract/17/12/3776 (674 words) |
|